Cleerly

AI-enabled CCTA solution for personalized heart attack prevention

Built from URL

HealthcareMedical DevicesDigital healthAIHealthTech

Breyer CapitalAI, AI Health, and Quantum

Aboutbreyer_capital_import

Cleerly’s AI-enabled approach to evaluating coronary computed tomography (CT) angiograms allows physicians to more easily identify, characterize and qualify atherosclerosis (plaque) build-up in the walls of the heart arteries.

ProblemBuilt from URL

Coronary Artery Disease (CAD) accounts for more than 900,000 fatalities a year, and current diagnostic methods may not accurately assess heart attack risk or provide comprehensive plaque analysis.

See something off about this company?